These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27178871)

  • 1. A novel Kir2.6 mutation associated with hypokalemic periodic paralysis.
    Zheng J; Liang Z; Hou Y; Liu F; Hu Y; Lin P; Yan C
    Clin Neurophysiol; 2016 Jun; 127(6):2503-8. PubMed ID: 27178871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis.
    Cheng CJ; Lin SH; Lo YF; Yang SS; Hsu YJ; Cannon SC; Huang CL
    J Biol Chem; 2011 Aug; 286(31):27425-35. PubMed ID: 21665951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of Kir2.6 channel by c-termini mutation D252N and its association with the susceptibility to Thyrotoxic Periodic Paralysis.
    Paninka RM; Carlos-Lima E; Lindsey SC; Kunii IS; Dias-da-Silva MR; Arcisio-Miranda M
    Neuroscience; 2017 Mar; 346():197-202. PubMed ID: 28131627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis.
    Ryan DP; da Silva MR; Soong TW; Fontaine B; Donaldson MR; Kung AW; Jongjaroenprasert W; Liang MC; Khoo DH; Cheah JS; Ho SC; Bernstein HS; Maciel RM; Brown RH; Ptácek LJ
    Cell; 2010 Jan; 140(1):88-98. PubMed ID: 20074522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome and exome sequencing realignment supports the assignment of KCNJ12, KCNJ17, and KCNJ18 paralogous genes in thyrotoxic periodic paralysis locus: functional characterization of two polymorphic Kir2.6 isoforms.
    Paninka RM; Mazzotti DR; Kizys MM; Vidi AC; Rodrigues H; Silva SP; Kunii IS; Furuzawa GK; Arcisio-Miranda M; Dias-da-Silva MR
    Mol Genet Genomics; 2016 Aug; 291(4):1535-44. PubMed ID: 27008341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andersen's syndrome mutants produce a knockdown of inwardly rectifying K
    Simkin D; Robin G; Giuliano S; Vukolic A; Moceri P; Guy N; Wagner KD; Lacampagne A; Allard B; Bendahhou S
    Cell Tissue Res; 2018 Feb; 371(2):309-323. PubMed ID: 29018970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro functional characterization of Andersen's syndrome mutations.
    Bendahhou S; Fournier E; Sternberg D; Bassez G; Furby A; Sereni C; Donaldson MR; Larroque MM; Fontaine B; Barhanin J
    J Physiol; 2005 Jun; 565(Pt 3):731-41. PubMed ID: 15831539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome.
    Ördög B; Hategan L; Kovács M; Seprényi G; Kohajda Z; Nagy I; Hegedűs Z; Környei L; Jost N; Katona M; Szekeres M; Forster T; Papp JG; Varró A; Sepp R
    Can J Physiol Pharmacol; 2015 Jul; 93(7):569-75. PubMed ID: 26103554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis.
    Li X; Yao S; Xiang Y; Zhang X; Wu X; Luo L; Huang H; Zhu M; Wan H; Hong D
    BMC Neurol; 2015 Mar; 15():38. PubMed ID: 25885757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Screening of Patients with Thyrotoxic Hypokalemic Periodic Paralysis: An Experience from a Tertiary Care Hospital in the Northeast of Brazil.
    Gbefon CY; Sobral CPS; Caldas A; Rocha VCC; Azulay RSS; Nascimento GC; Damianse SSP; Gaspar SAS; Faria MS; Magalhães M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2231-2237. PubMed ID: 34554906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kir2.6 regulates the surface expression of Kir2.x inward rectifier potassium channels.
    Dassau L; Conti LR; Radeke CM; Ptáček LJ; Vandenberg CA
    J Biol Chem; 2011 Mar; 286(11):9526-41. PubMed ID: 21209095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred.
    Bendahhou S; Fournier E; Gallet S; Ménard D; Larroque MM; Barhanin J
    Hum Mol Genet; 2007 Apr; 16(8):900-6. PubMed ID: 17324964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodic paralysis.
    Fontaine B
    Adv Genet; 2008; 63():3-23. PubMed ID: 19185183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does thyrotoxic periodic paralysis have a genetic predisposition? A case report.
    Rasheed E; Seheult J; Gibney J; Boran G
    Ann Clin Biochem; 2018 Nov; 55(6):713-716. PubMed ID: 29886759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.
    Hattori T; Makiyama T; Akao M; Ehara E; Ohno S; Iguchi M; Nishio Y; Sasaki K; Itoh H; Yokode M; Kita T; Horie M; Kimura T
    Cardiovasc Res; 2012 Mar; 93(4):666-73. PubMed ID: 22155372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kir2.2 p.Thr140Met: a genetic susceptibility to sporadic periodic paralysis.
    Fan C; Kuhn M; Mbiol AP; Groome J; Winston V; Biskup S; Lehmann-Horn F; Jurkat-Rott K
    Acta Myol; 2018 Sep; 37(3):193-203. PubMed ID: 30838349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome.
    Preisig-Müller R; Schlichthörl G; Goerge T; Heinen S; Brüggemann A; Rajan S; Derst C; Veh RW; Daut J
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7774-9. PubMed ID: 12032359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare KCNJ18 variants do not explain hypokalaemic periodic paralysis in 263 unrelated patients.
    Kuhn M; Jurkat-Rott K; Lehmann-Horn F
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):49-52. PubMed ID: 25882930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic paralysis due to cumulative effects of rare variants in SCN4A with small functional alterations.
    Shibano M; Kubota T; Kokubun N; Miyaji Y; Kuriki H; Ito Y; Hamanoue H; Takahashi MP
    Muscle Nerve; 2022 Dec; 66(6):757-761. PubMed ID: 36116128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired interaction between the slide helix and the C-terminus of Kir2.1: a novel mechanism of Andersen syndrome.
    Decher N; Renigunta V; Zuzarte M; Soom M; Heinemann SH; Timothy KW; Keating MT; Daut J; Sanguinetti MC; Splawski I
    Cardiovasc Res; 2007 Sep; 75(4):748-57. PubMed ID: 17568571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.